To explore the link between transactivation and tumor suppression, here we compare the findings from the yeast screen study with available human p53 mutation data to correlate specific point mutations showing loss or retained transactivation function with the incidence of the same substitution in human cancer. This evidence concerns the gene TP53 and cancer.